[ad_1]
The TB Alliance announced yesterday that Indian pharmaceutical company Macleods will start manufacturing an essential component of the shorter, all-oral drug regimen for drug-resistant tuberculosis (DR-TB). Under a licensing agreement with the …
|
Sources 2/ https://www.cidrap.umn.edu/antimicrobial-stewardship/indian-drugmaker-supply-key-component-drug-resistant-tb-regimens The mention sources can contact us to remove/changing this article |
[ad_2]